How the Cancer Genome Atlas has impacted bladder Ca management

The Cancer Genome Atlas (TCGA), a joint research effort of the National Cancer Institute and the National Human Genome Research Institute, has provided a “complete genomic roadmap” of muscle-invasive bladder cancer, according to Seth P. Lerner, MD, co-chair of the Analysis Working Group of the TCGA program for muscle-invasive bladder cancer. Dr. Lerner, of Baylor College of Medicine in Houston, talks to Urology Times about the clinical relevance of the TCGA’s findings, possible implications for upper tract disease, and what further research is needed.